Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2025 financial results on Thursday, May 1, 2025 at 7:30 a.m. Central Time. To ...

D EERFIELD, IL – Baxter International Inc. (NYSE:BAX), a global leader in medical products with a market capitalization of $16.65 billion and annual revenue of $15.06 billion, announced today ...

DEERFIELD, Ill., March 26, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2025 Annual Meeting) in a virtual ...

Baxter International Inc. (NYSE:BAX) also enhances its portfolio and global reach through strategic acquisitions, such as its purchase of Hillrom. The business’s Q4 2024 financial report which was ...

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion ...

Hemopatch Sealing Hemostat has offered surgeons a reliable solution for tissue sealing, dura sealing, and hemostasis,” said Steve Wallace, president, Advanced Surgery at Baxter. “The product evolution ...

He is the former chairman and chief executive officer of Baxter International Inc., a $12 billion global healthcare company. Harry has been named Kellogg School Professor of the Year for the Fulltime ...

Michael Baxter joined Faegre Drinker as a partner in the corporate group in Philadelphia, the firm announced Wednesday.